Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations

Cancer Res (2022) 82 (4_Supplement): GS2-09.

https://doi.org/10.1158/1538-7445.SABCS21-GS2-09

Published: 15 February 2022

View articletitled, Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations

Journal Articles

Abstract 4044: Draining lymph nodes in ovarian cancer patients have a naïve immune cell signature

Kim Brunekreeft, Fenne Komdeur, Hagma Workel, Florine Eggink, Annechien Plat, Refika Yigit, Harry Hollema, Evelien Duiker, Hans Nijman, Marco Bruyn

Cancer Res (2018) 78 (13_Supplement): 4044.

https://doi.org/10.1158/1538-7445.AM2018-4044

Published: 01 July 2018

View articletitled, Abstract 4044: Draining lymph nodes in ovarian cancer patients have a naïve immune cell signature

Journal Articles

Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas

Marjolein Droog, Ekaterina Nevedomskaya, Yongsoo Kim, Tesa Severson, Koen D. Flach, Mark Opdam, Karianne Schuurman, Patrycja Gradowska, Michael Hauptmann, Gwen Dackus, Harry Hollema, Marian J. Mourits, Petra Nederlof, Hester van Boven, Sabine C. Linn, Lodewyk Wessels, Flora E. van Leeuwen, Wilbert Zwart

Cancer Res (2016) 76 (13): 3773–3784.

https://doi.org/10.1158/0008-5472.CAN-14-1813

Published: 30 June 2016

View articletitled, Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas

Includes: Supplementary data

Journal Articles

Abstract 4768: Frequency and prognostic value of hormone receptor expression in epithelial ovarian cancer.

Michel van Kruchten, Pauline W. van der Marel, Henriëtte J.G. Arts, Harry Hollema, Linda de Munck, Tineke van der Sluis, Hetty Timmer-Bosscha, Geke A.P. Hospers, An K.L. Reyners

Cancer Res (2013) 73 (8_Supplement): 4768.

https://doi.org/10.1158/1538-7445.AM2013-4768

Published: 15 April 2013

View articletitled, Abstract 4768: Frequency and prognostic value of hormone receptor expression in epithelial ovarian cancer.

Journal Articles

Abstract 3641: The predictive and prognostic roles of DNA damage response genes in epithelial ovarian cancer

Nicolette G. Alkema, Marieke Everts, Ate G.J. van der Zee, Klaske A. ten Hoor, Harry Hollema, Steven de Jong, Marcel A.T.M. van Vugt, Bea G.B.A. Wisman

Cancer Res (2012) 72 (8_Supplement): 3641.

https://doi.org/10.1158/1538-7445.AM2012-3641

Published: 15 April 2012

View articletitled, Abstract 3641: The predictive and prognostic roles of DNA damage response genes in epithelial ovarian cancer

Journal Articles

Abstract 5011: Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia

Agnes Lendvai, Frank Johannes, Christina Grimm, Jasper JH Eijsink, Rene Wardenaar, Haukeline H. Volders, Harry G. Klip, Harry Hollema, Ritsert C. Jansen, Ed Schuuring, Ate GJ van der Zee, G. Bea A. Wisman

Cancer Res (2012) 72 (8_Supplement): 5011.

https://doi.org/10.1158/1538-7445.AM2012-5011

Published: 15 April 2012

View articletitled, Abstract 5011: Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia

Journal Articles

VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment

Wouter B. Nagengast, Marjolijn N. Lub-de Hooge, Sjoukje F. Oosting, Wilfred F.A. den Dunnen, Frank-Jan Warnders, Adrienne H. Brouwers, Johan R. de Jong, Patricia M. Price, Harry Hollema, Geke A.P. Hospers, Philip H. Elsinga, Jan Willem Hesselink, Jourik A. Gietema, Elisabeth G.E. de Vries

Cancer Res (2011) 71 (1): 143–153.

https://doi.org/10.1158/0008-5472.CAN-10-1088

Published: 02 January 2011

View articletitled, VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment

Includes: Supplementary data

Journal Articles

Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma

Gerben Duns, Eva van den Berg, Inge van Duivenbode, Jan Osinga, Harry Hollema, Robert M.W. Hofstra, Klaas Kok

Cancer Res (2010) 70 (11): 4287–4291.

https://doi.org/10.1158/0008-5472.CAN-10-0120

Published: 01 June 2010

View articletitled, Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma

Includes: Supplementary data

Journal Articles

Abstract 161: Discovery of novel methylation-based biomarkers for epithelial ovarian cancer using oligonucleotide microarrays

Pauline de Graeff, Bea Wisman, Rudolf SN Fehrmann, Anne PG Crijns, Gert Jan Meersma, Haukeline H. Volders, Iris Blijdorp, Marian JE Mourits, Harry Hollema, Steven de Jong, Ate GJ van der Zee

Cancer Res (2010) 70 (8_Supplement): 161.

https://doi.org/10.1158/1538-7445.AM10-161

Published: 15 April 2010

View articletitled, Abstract 161: Discovery of novel methylation-based biomarkers for epithelial ovarian cancer using oligonucleotide microarrays

Journal Articles

Abstract 4917: A four-gene methylation marker panel as triage test in hr-HPV positive patients

Jasper JH Eijsink, Agnes Lendvai, Valerie Deregowski, Harry G. Klip, Gonda Verpooten, Luc Dehaspe, Geertruida H. de Bock, Harry Hollema, Wim van Criekinge, Ed Schuuring, Ate GJ van der Zee, Bea Wisman

Cancer Res (2010) 70 (8_Supplement): 4917.

https://doi.org/10.1158/1538-7445.AM10-4917

Published: 15 April 2010

View articletitled, Abstract 4917: A four-gene methylation marker panel as triage test in hr-HPV positive patients

Journal Articles

Abstract #5014: ⁸⁹ Zr-ranibizumab VEGF microPET imaging during sunitinib treatment visualizes changes with low tracer uptake in the center of the tumor and high uptake at the rim with a rebound tumor uptake after end of treatment.

Wouter Nagengast, Marjolijn Lub-de Hooge, Jourik Gietema, Sjoukje Oosting, Frank-Jan Warnders, Maarten de Korte, Hetty Timmer-Boscha, Johan de Jong, Geke Hospers, Wilfred den Dunnen, Harry Hollema, Elisabeth de Vries

Cancer Res (2009) 69 (9_Supplement): 5014.

Published: 01 May 2009

View articletitled, Abstract #5014: 89 Zr-ranibizumab VEGF microPET imaging during sunitinib treatment visualizes changes with low tracer uptake in the center of the tumor and high uptake at the rim with a rebound tumor uptake after end of treatment.

Journal Articles

Abstract #3878: An integrated bioinformatics and functional approach to identify genes and pathways related to platinum resistance in ovarian cancer

Rudolf Fehrmann, Pauline de Graeff, Anne Crijns, Gert Jan Meersma, Harry Klip, Harry Hollema, Gerard te Meerman, Elisabeth de Vries, Ate van der Zee, Steven de Jong

Cancer Res (2009) 69 (9_Supplement): 3878.

Published: 01 May 2009

View articletitled, Abstract #3878: An integrated bioinformatics and functional approach to identify genes and pathways related to platinum resistance in ovarian cancer

Journal Articles

Gene promoter methylation pattern in cervical cancer

Nan Yang, Henriette J Arts, Esther R. Nijhuis, Agnes Lendvai, Klaske A. ten Hoor, Haukeline H. Volders, Jelmer J. van Zanden, Jasper J.H. Eijsink, Harry Hollema, Ed Schuuring, G. Bea A. Wisman, Ate G.J. van der Zee

Cancer Res (2007) 67 (9_Supplement): 1787.

Published: 01 May 2007

View articletitled, Gene promoter methylation pattern in cervical cancer

Journal Articles

The ErbB signalling pathway: Protein expression and prognostic value in epithelial ovarian cancer

Pauline de Graeff, Anne Crijns, Klaske ten Hoor, Harry Klip, Harry Hollema, Karin Oien, John Bartlett, G. Bea Wisman, Geertruida de Bock, Steven de Jong, Ate van der Zee

Cancer Res (2007) 67 (9_Supplement): 5036.

Published: 01 May 2007

View articletitled, The ErbB signalling pathway: Protein expression and prognostic value in epithelial ovarian cancer

Journal Articles

Genomic aberrations in uterine corpus cancers subsequent to use of tamoxifen for breast cancer

Wilhelmina E. Hoogendoorn, Renske Fles, Hester H. Van Boven, Harry Hollema, Marian J. Mourits, Flora E. Van Leeuwen, Petra M. Nederlof

Cancer Res (2006) 66 (8_Supplement): 284.

Published: 15 April 2006

View articletitled, Genomic aberrations in uterine corpus cancers subsequent to use of tamoxifen for breast cancer

Journal Articles

Assessment of gene promoter hypermethylation for detection of cervical neoplasia, a pilot study

G Bea A. Wisman, Esther R. Nijhuis, Mohammad O. Hoque, Alice J. Koning, Nathalie Reesink-Peters, Henk J. Buikema, Ed M. D. Schuuring, Harry Hollema, David Sidransky, Ate G. J. Van der Zee

Cancer Res (2005) 65 (9_Supplement): 650.

Published: 01 May 2005

View articletitled, Assessment of gene promoter hypermethylation for detection of cervical neoplasia, a pilot study

Journal Articles

RET-Familial Medullary Thyroid Carcinoma Mutants Y791F and S891A Activate a Src/JAK/STAT3 Pathway, Independent of Glial Cell Line–Derived Neurotrophic Factor

Ivan Plaza Menacho, Roelof Koster, Almer M. van der Sloot, Wim J. Quax, Jan Osinga, Tineke van der Sluis, Harry Hollema, Grzegorz M. Burzynski, Oliver Gimm, Charles H.C.M. Buys, Bart J.L. Eggen, Robert M.W. Hofstra

Cancer Res (2005) 65 (5): 1729–1737.

https://doi.org/10.1158/0008-5472.CAN-04-2363

Published: 07 March 2005

View articletitled, RET-Familial Medullary Thyroid Carcinoma Mutants Y791F and S891A Activate a Src/JAK/STAT3 Pathway, Independent of Glial Cell Line–Derived Neurotrophic Factor

Journal Articles

Quantitative tumor suppressor gene hypermethylation assay (QMSP) in cervical cancer: A comparison between cervical scrapings and tissue samples

Nathalie Reesink-Peters, G. Bea A. Wisman, Carmen Jerónimo, Yutaka Tokumaru, Yoram Cohen, Seung Myung Dong, Harry Klip, Henk J. Buikema, Albert J. H. Suurmeijer, Harry Hollema, Marike Boezen, David Sidransky, Ate G. J. Van der Zee

Cancer Res (2004) 64 (7_Supplement): 243.

Published: 01 April 2004

View articletitled, Quantitative tumor suppressor gene hypermethylation assay (QMSP) in cervical cancer: A comparison between cervical scrapings and tissue samples

Journal Articles

Loss of MSH2 expression is a risk factor in early stage cervical cancer

Esther R. Nijhuis, Hans W. Nijman, Nathalie Reesink, Harry Hollema, Klaske A. Ten Hoor, Ate G. Van der Zee

Cancer Res (2004) 64 (7_Supplement): 441.

Published: 01 April 2004

View articletitled, Loss of MSH2 expression is a risk factor in early stage cervical cancer

Journal Articles

Wnt pathway activation in colorectal tumors is associated with an increase in DR4 expression.

Mathilde Jalving, Jan J. Koornstra, Wytske Boersma-Van ek, Nynke Zwart, Harry Hollema, Elisabeth G. De Vries, Steven De Jong, Jan H. Kleibeuker

Cancer Res (2004) 64 (7_Supplement): 824.

Published: 01 April 2004

View articletitled, Wnt pathway activation in colorectal tumors is associated with an increase in DR4 expression.

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations

Abstract 4044: Draining lymph nodes in ovarian cancer patients have a naïve immune cell signature

Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas

Abstract 4768: Frequency and prognostic value of hormone receptor expression in epithelial ovarian cancer.

Abstract 3641: The predictive and prognostic roles of DNA damage response genes in epithelial ovarian cancer

Abstract 5011: Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia

VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment

Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma

Abstract 161: Discovery of novel methylation-based biomarkers for epithelial ovarian cancer using oligonucleotide microarrays

Abstract 4917: A four-gene methylation marker panel as triage test in hr-HPV positive patients

Abstract #5014: ⁸⁹ Zr-ranibizumab VEGF microPET imaging during sunitinib treatment visualizes changes with low tracer uptake in the center of the tumor and high uptake at the rim with a rebound tumor uptake after end of treatment.

Abstract #3878: An integrated bioinformatics and functional approach to identify genes and pathways related to platinum resistance in ovarian cancer

Gene promoter methylation pattern in cervical cancer

The ErbB signalling pathway: Protein expression and prognostic value in epithelial ovarian cancer

Genomic aberrations in uterine corpus cancers subsequent to use of tamoxifen for breast cancer

Assessment of gene promoter hypermethylation for detection of cervical neoplasia, a pilot study

RET-Familial Medullary Thyroid Carcinoma Mutants Y791F and S891A Activate a Src/JAK/STAT3 Pathway, Independent of Glial Cell Line–Derived Neurotrophic Factor

Quantitative tumor suppressor gene hypermethylation assay (QMSP) in cervical cancer: A comparison between cervical scrapings and tissue samples

Loss of MSH2 expression is a risk factor in early stage cervical cancer

Wnt pathway activation in colorectal tumors is associated with an increase in DR4 expression.

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only